Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

By | January 25, 2022
In a new study, researchers assessed the extent and duration of the neutralization of SARS-CoV-2 Omicron variant of concern after the administration of two and three doses of the BNT162b2 mRNA vaccine.